|23.76||+1.23 / +5.46%|
As of 4:00pm ET
|23.76||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 32.00, with a high estimate of 35.00 and a low estimate of 31.00. The median estimate represents a +34.68% increase from the last price of 23.76.
The current consensus among 4 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.